KromaTiD's directional genomic hybridization (dGH) platform uses single-stranded probes to discover, detect, and diagnose structural variants like inversions and translocations at high resolution on a cell-by-cell basis. This complements next-generation sequencing and microarrays. dGH assays can find inherited, spontaneous, and induced mutations. PinPoint FISH assays then allow targeted detection of variants identified by dGH. KromaTiD offers both research services using its techniques and collaboration with customer labs.